Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flecainide for early sinus rhythm conversion of perioperative AF
NCT06142604Phase 4Withdrawn
- Sponsor
- Population Health Research Institute
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of flecainide in Atrial fibrillation (AFib), sponsored by Population Health Research Institute. Planned start Jul 2024; status: withdrawn.
02
Drugs
flecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06142604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06142604.